Annual report
6063.TEDINET S100XUYQ
Period2025-01-01 → 2025-12-31
Filed2026-03-27
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 152
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥3.7bn | 2025-01-01 → 2025-12-31 | Cons. | Net sales |
| Revenue | ¥2.9bn | 2024-01-01 → 2024-12-31 | Cons. | Net sales |
| Revenue | ¥3.6bn | 2023-01-01 → 2023-12-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥6.2bn | 2022-01-01 → 2022-12-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥4.4bn | 2021-01-01 → 2021-12-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥96m | 2025-01-01 → 2025-12-31 | Cons. | Operating income |
| Operating income | ¥52m | 2024-01-01 → 2024-12-31 | Cons. | Operating income |
| Ordinary income | ¥104m | 2025-01-01 → 2025-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥64m | 2024-01-01 → 2024-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥181m | 2023-01-01 → 2023-12-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥730m | 2022-01-01 → 2022-12-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥244m | 2021-01-01 → 2021-12-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥121m | 2025-01-01 → 2025-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥63m | 2024-01-01 → 2024-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥102m | 2025-01-01 → 2025-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥48m | 2024-01-01 → 2024-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥120m | 2023-01-01 → 2023-12-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥500m | 2022-01-01 → 2022-12-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥179m | 2021-01-01 → 2021-12-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥102m | 2025-01-01 → 2025-12-31 | Cons. | Profit loss |
| Net income | ¥48m | 2024-01-01 → 2024-12-31 | Cons. | Profit loss |
| Total assets | ¥3.8bn | at 2025-12-31 | Cons. | Assets |
| Total assets | ¥3.8bn | at 2024-12-31 | Cons. | Assets |
| Total assets | ¥3.7bn | at 2023-12-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥3.9bn | at 2022-12-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥3.8bn | at 2021-12-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥1.9bn | at 2025-12-31 | Cons. | Liabilities |
| Total liabilities | ¥2.0bn | at 2024-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥1.9bn | at 2025-12-31 | Cons. | Net assets |
| Net assets / equity | ¥1.8bn | at 2024-12-31 | Cons. | Net assets |
| Net assets / equity | ¥1.7bn | at 2023-12-31v | Cons. | Net assets |
| Net assets / equity | ¥1.6bn | at 2022-12-31v | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥1.1bn | at 2021-12-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.5bn | at 2025-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥2.3bn | at 2024-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥2.3bn | at 2025-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.2bn | at 2024-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.2bn | at 2023-12-31v | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.3bn | at 2022-12-31v | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥1.7bn | at 2021-12-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥296m | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥40m | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥5m | 2023-01-01 → 2023-12-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥920m | 2022-01-01 → 2022-12-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥245m | 2021-01-01 → 2021-12-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥86m | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥112m | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥43m | 2023-01-01 → 2023-12-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥63m | 2022-01-01 → 2022-12-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥17m | 2021-01-01 → 2021-12-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥119m | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥79m | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥100m | 2023-01-01 → 2023-12-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥310m | 2022-01-01 → 2022-12-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥353m | 2021-01-01 → 2021-12-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥40.44 | 2025-01-01 → 2025-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥19.06 | 2024-01-01 → 2024-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥47.63 | 2023-01-01 → 2023-12-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥198.5 | 2022-01-01 → 2022-12-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥71 | 2021-01-01 → 2021-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥198.42 | 2022-01-01 → 2022-12-31v | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥70.96 | 2021-01-01 → 2021-12-31d | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥737.9 | at 2025-12-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥697.06 | at 2024-12-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥663.3 | at 2023-12-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥624.46 | at 2022-12-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥419.16 | at 2021-12-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 48.7% | at 2025-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 46.1% | at 2024-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 45.3% | at 2023-12-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 40.0% | at 2022-12-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 27.8% | at 2021-12-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 5.6% | 2025-01-01 → 2025-12-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 2.8% | 2024-01-01 → 2024-12-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 7.4% | 2023-01-01 → 2023-12-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 38.0% | 2022-01-01 → 2022-12-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 18.9% | 2021-01-01 → 2021-12-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 247 | at 2025-12-31 | Cons. | Number of employees |
| Employees | 229 | at 2024-12-31 | Cons. | Number of employees |
| Employees | 229 | at 2023-12-31v | Cons. | Number of employees |
| Employees | 234 | at 2022-12-31v | Cons. | Number of employees |
| Employees | 251 | at 2021-12-31d | Cons. | Number of employees |
| Revenue | ¥3.6bn | 2025-01-01 → 2025-12-31 | Standalone | Net sales |
| Revenue | ¥2.9bn | 2024-01-01 → 2024-12-31 | Standalone | Net sales |
| Revenue | ¥3.6bn | 2023-01-01 → 2023-12-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥6.2bn | 2022-01-01 → 2022-12-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥4.3bn | 2021-01-01 → 2021-12-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥40m | 2025-01-01 → 2025-12-31 | Standalone | Operating income |
| Operating income | ¥15m | 2024-01-01 → 2024-12-31 | Standalone | Operating income |
| Ordinary income | ¥94m | 2025-01-01 → 2025-12-31 | Standalone | Ordinary income |
| Ordinary income | ¥22m | 2024-01-01 → 2024-12-31 | Standalone | Ordinary income |
| Ordinary income | ¥153m | 2023-01-01 → 2023-12-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥700m | 2022-01-01 → 2022-12-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥219m | 2021-01-01 → 2021-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥111m | 2025-01-01 → 2025-12-31 | Standalone | Income before income taxes |
| Profit before tax | ¥24m | 2024-01-01 → 2024-12-31 | Standalone | Income before income taxes |
| Net income | ¥95m | 2025-01-01 → 2025-12-31 | Standalone | Profit loss |
| Net income | ¥11m | 2024-01-01 → 2024-12-31 | Standalone | Profit loss |
| Net income | ¥99m | 2023-01-01 → 2023-12-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥477m | 2022-01-01 → 2022-12-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥154m | 2021-01-01 → 2021-12-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥3.3bn | at 2025-12-31 | Standalone | Assets |
| Total assets | ¥3.3bn | at 2024-12-31 | Standalone | Assets |
| Total assets | ¥3.3bn | at 2023-12-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥3.6bn | at 2022-12-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥3.5bn | at 2021-12-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥1.9bn | at 2025-12-31 | Standalone | Liabilities |
| Total liabilities | ¥2.0bn | at 2024-12-31 | Standalone | Liabilities |
| Net assets / equity | ¥1.4bn | at 2025-12-31 | Standalone | Net assets |
| Net assets / equity | ¥1.3bn | at 2024-12-31 | Standalone | Net assets |
| Net assets / equity | ¥1.3bn | at 2023-12-31v | Standalone | Net assets |
| Net assets / equity | ¥1.3bn | at 2022-12-31v | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥803m | at 2021-12-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥2.0bn | at 2025-12-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥1.8bn | at 2024-12-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥37.69 | 2025-01-01 → 2025-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥4.47 | 2024-01-01 → 2024-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥39.15 | 2023-01-01 → 2023-12-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥189.49 | 2022-01-01 → 2022-12-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥61.31 | 2021-01-01 → 2021-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥189.42 | 2022-01-01 → 2022-12-31v | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥61.27 | 2021-01-01 → 2021-12-31d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥9 | 2025-01-01 → 2025-12-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥8 | 2024-01-01 → 2024-12-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥10 | 2023-01-01 → 2023-12-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥18 | 2022-01-01 → 2022-12-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥10 | 2021-01-01 → 2021-12-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥533.61 | at 2025-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥503.93 | at 2024-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥504.46 | at 2023-12-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥488.31 | at 2022-12-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥308.82 | at 2021-12-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 40.8% | at 2025-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 38.1% | at 2024-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 38.8% | at 2023-12-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 34.1% | at 2022-12-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 22.1% | at 2021-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 7.3% | 2025-01-01 → 2025-12-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 0.9% | 2024-01-01 → 2024-12-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.9% | 2023-01-01 → 2023-12-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 47.5% | 2022-01-01 → 2022-12-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 22.0% | 2021-01-01 → 2021-12-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 2,519,600 | at 2025-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,519,600 | at 2024-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,519,600 | at 2023-12-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,519,600 | at 2022-12-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,519,600 | at 2021-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 169 | at 2025-12-31 | Standalone | Number of employees |
| Employees | 156 | at 2024-12-31 | Standalone | Number of employees |
| Employees | 164 | at 2023-12-31v | Standalone | Number of employees |
| Employees | 169 | at 2022-12-31v | Standalone | Number of employees |
| Employees | 179 | at 2021-12-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 46
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2025-01-01 → 2025-12-31 | ¥1m |
| Reconciling Itemsreconciling | depreciation | 2025-01-01 → 2025-12-31 | ¥2m |
| Reconciling Itemsreconciling | segment assets | at 2025-12-31 | ¥2.1bn |
| Reconciling Itemsreconciling | segment profit | 2025-01-01 → 2025-12-31 | −¥535m |
| Life Assitance Departmentreportable segment | capex | 2025-01-01 → 2025-12-31 | ¥2m |
| Life Assitance Departmentreportable segment | depreciation | 2025-01-01 → 2025-12-31 | ¥11m |
| Life Assitance Departmentreportable segment | employees | at 2025-12-31 | 37 pure |
| Life Assitance Departmentreportable segment | revenue | 2025-01-01 → 2025-12-31 | ¥484m |
| Life Assitance Departmentreportable segment | revenue external | 2025-01-01 → 2025-12-31 | ¥484m |
| Life Assitance Departmentreportable segment | segment assets | at 2025-12-31 | ¥14m |
| Life Assitance Departmentreportable segment | segment profit | 2025-01-01 → 2025-12-31 | ¥114m |
| Medical Assistance Departmentreportable segment | capex | 2025-01-01 → 2025-12-31 | ¥33m |
| Medical Assistance Departmentreportable segment | depreciation | 2025-01-01 → 2025-12-31 | ¥32m |
| Medical Assistance Departmentreportable segment | employees | at 2025-12-31 | 186 pure |
| Medical Assistance Departmentreportable segment | revenue | 2025-01-01 → 2025-12-31 | ¥3.2bn |
| Medical Assistance Departmentreportable segment | revenue external | 2025-01-01 → 2025-12-31 | ¥3.2bn |
| Medical Assistance Departmentreportable segment | segment assets | at 2025-12-31 | ¥1.7bn |
| Medical Assistance Departmentreportable segment | segment profit | 2025-01-01 → 2025-12-31 | ¥516m |
| —segment total | capex | 2025-01-01 → 2025-12-31 | ¥35m |
| —segment total | depreciation | 2025-01-01 → 2025-12-31 | ¥43m |
| —segment total | revenue | 2025-01-01 → 2025-12-31 | ¥3.7bn |
| —segment total | revenue external | 2025-01-01 → 2025-12-31 | ¥3.7bn |
| —segment total | segment assets | at 2025-12-31 | ¥1.7bn |
| —segment total | segment profit | 2025-01-01 → 2025-12-31 | ¥631m |
| Reconciling Itemsreconciling | depreciation | 2024-01-01 → 2024-12-31 | ¥3m |
| Reconciling Itemsreconciling | segment assets | at 2024-12-31 | ¥2.0bn |
| Reconciling Itemsreconciling | segment profit | 2024-01-01 → 2024-12-31 | −¥487m |
| Life Assitance Departmentreportable segment | depreciation | 2024-01-01 → 2024-12-31 | ¥11m |
| Life Assitance Departmentreportable segment | revenue | 2024-01-01 → 2024-12-31 | ¥450m |
| Life Assitance Departmentreportable segment | revenue external | 2024-01-01 → 2024-12-31 | ¥450m |
| Life Assitance Departmentreportable segment | segment assets | at 2024-12-31 | ¥19m |
| Life Assitance Departmentreportable segment | segment profit | 2024-01-01 → 2024-12-31 | ¥101m |
| Medical Assistance Departmentreportable segment | capex | 2024-01-01 → 2024-12-31 | ¥44m |
| Medical Assistance Departmentreportable segment | depreciation | 2024-01-01 → 2024-12-31 | ¥33m |
| Medical Assistance Departmentreportable segment | revenue | 2024-01-01 → 2024-12-31 | ¥2.5bn |
| Medical Assistance Departmentreportable segment | revenue external | 2024-01-01 → 2024-12-31 | ¥2.5bn |
| Medical Assistance Departmentreportable segment | segment assets | at 2024-12-31 | ¥1.8bn |
| Medical Assistance Departmentreportable segment | segment profit | 2024-01-01 → 2024-12-31 | ¥439m |
| —segment total | capex | 2024-01-01 → 2024-12-31 | ¥44m |
| —segment total | depreciation | 2024-01-01 → 2024-12-31 | ¥44m |
| —segment total | revenue | 2024-01-01 → 2024-12-31 | ¥2.9bn |
| —segment total | revenue external | 2024-01-01 → 2024-12-31 | ¥2.9bn |
| —segment total | segment assets | at 2024-12-31 | ¥1.8bn |
| —segment total | segment profit | 2024-01-01 → 2024-12-31 | ¥540m |
| Life Assitance Departmentreportable segment | employees | at 2025-12-31 | 37 pure |
| Medical Assistance Departmentreportable segment | employees | at 2025-12-31 | 108 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,262
| Item | Context | Value | Unit |
|---|---|---|---|
| Total assets (5-year summary) | Prior3YearInstant | 3932841000 | JPY |
| Total assets (5-year summary) | Prior2YearInstant | 3685357000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 3807673000 | JPY |
| Total assets (5-year summary) | CurrentYearInstant | 3813957000 | JPY |
| Net assets per share (5-year summary) | Prior4YearInstant | 419.16 | |
| Net assets per share (5-year summary) | Prior3YearInstant | 624.46 | |
| Net assets per share (5-year summary) | Prior2YearInstant | 663.30 | |
| Net assets per share (5-year summary) | Prior1YearInstant | 697.06 | |
| Net assets per share (5-year summary) | CurrentYearInstant | 737.90 | |
| Basic earnings loss per share (5-year summary) | Prior4YearDuration | 71.00 | |
| Basic earnings loss per share (5-year summary) | Prior3YearDuration | 198.50 | |
| Basic earnings loss per share (5-year summary) | Prior2YearDuration | 47.63 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 19.06 | |
| Basic earnings loss per share (5-year summary) | CurrentYearDuration | 40.44 | |
| Diluted earnings per share (5-year summary) | Prior4YearDuration | 70.96 | |
| Diluted earnings per share (5-year summary) | Prior3YearDuration | 198.42 | |
| Diluted earnings per share (5-year summary) | Prior2YearDuration | － | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | － | |
| Diluted earnings per share (5-year summary) | CurrentYearDuration | － | |
| Equity to asset ratio (5-year summary) | Prior4YearInstant | 0.278 | |
| Equity to asset ratio (5-year summary) | Prior3YearInstant | 0.400 | |
| Equity to asset ratio (5-year summary) | Prior2YearInstant | 0.453 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.461 | |
| Equity to asset ratio (5-year summary) | CurrentYearInstant | 0.487 | |
| Rate of return on equity (5-year summary) | Prior4YearDuration | 0.189 | |
| Rate of return on equity (5-year summary) | Prior3YearDuration | 0.380 | |
| Rate of return on equity (5-year summary) | Prior2YearDuration | 0.074 | |
| Rate of return on equity (5-year summary) | Prior1YearDuration | 0.028 | |
| Rate of return on equity (5-year summary) | CurrentYearDuration | 0.056 | |
| Price earnings ratio (5-year summary) | Prior4YearDuration | 14.93 | |
| Price earnings ratio (5-year summary) | Prior3YearDuration | 5.36 | |
| Price earnings ratio (5-year summary) | Prior2YearDuration | 16.96 | |
| Price earnings ratio (5-year summary) | Prior1YearDuration | 46.90 | |
| Price earnings ratio (5-year summary) | CurrentYearDuration | 22.77 | |
| Net cash provided by used in operating activities (5-year summary) | Prior4YearDuration | -245045000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior3YearDuration | 920227000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior2YearDuration | -5491000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior1YearDuration | -39844000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | CurrentYearDuration | 295748000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior4YearDuration | -16833000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior3YearDuration | -63116000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior2YearDuration | -43401000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YearDuration | -111943000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | CurrentYearDuration | -85628000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior4YearDuration | 353107000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior3YearDuration | -309891000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior2YearDuration | -99554000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YearDuration | 79459000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | CurrentYearDuration | -119479000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior4YearInstant | 1708771000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |